Galvanize Therapeutics Welcomes Laura Francis to Board of Directors, Strengthening Leadership Team Galvanize Therapeutics has appointed Laura Francis, experienced in the medical technology space, to its Board of Directors to enhance company leadership.

Galvanize Therapeutics Welcomes Laura Francis to Board of Directors, Strengthening Leadership Team #USA #Redwood_City #medical_technology #Galvanize_Therapeutics #Laura_Francis

New Breakthrough in Cancer Treatment: Aliya® PEF Shows Promise in Controlling Lung Tumors Recent findings from a clinical study reveal that Aliya® Pulsed Electric Field Ablation effectively controls lung tumors and may enhance immune responses in patients with advanced cancer.

New Breakthrough in Cancer Treatment: Aliya® PEF Shows Promise in Controlling Lung Tumors #United_States #Redwood_City #Lung_Cancer #Aliya_PEF #Galvanize_Therapeutics

Galvanize Therapeutics Secures $100 Million for Innovative Cancer and Lung Disease Treatments Galvanize Therapeutics has raised $100 million in Series C funding, aiming to revolutionize treatments for cancer and chronic lung disease with its unique PEF technology.

Galvanize Therapeutics Secures $100 Million for Innovative Cancer and Lung Disease Treatments #United_States #Redwood_City #Galvanize_Therapeutics #Sofinnova_Partners #PEF_Technology

Galvanize Launches PROPEL Registry to Study Aliya® PEF Ablation for Soft Tissue Lesions Galvanize Therapeutics has enrolled its first patient in the PROPEL Registry, a significant step in assessing Aliya® PEF ablation's efficacy for soft tissue lesions.

Galvanize Launches PROPEL Registry to Study Aliya® PEF Ablation for Soft Tissue Lesions #United_States #Redwood_City #Aliya_PEF #Galvanize_Therapeutics #PROPEL_Registry